Novocure Announces Clinical Trial Collaboration with Roche to Evaluate Tumor Treating Fields as Part of a Novel Combination for the First-Line Treatment of Metastatic Pancreatic Cancer

Novocure announced that it has entered into a clinical trial collaboration agreement with Roche, to develop Tumor Treating Fields together with Roche’s anti-PD-L1 therapy, atezolizumab, in metastatic pancreatic ductal adenocarcinoma.